INTRAOCULAR PRESSURE-LOWERING AGENT COMPRISING COMPOUND HAVING HISTONE DEACETYLASE INHIBITORY EFFECT AS ACTIVE INGREDIENT
The object is to find a novel pharmacological activity of a compound capa ble of inhibiting an HDAC. The compound capable of inhibiting a histone deac etylase has an excellent ability of changing the cytomorphology of a trabecu lara cell and/or an excellent ocular hypotensive activity, and is theref...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The object is to find a novel pharmacological activity of a compound capa ble of inhibiting an HDAC. The compound capable of inhibiting a histone deac etylase has an excellent ability of changing the cytomorphology of a trabecu lara cell and/or an excellent ocular hypotensive activity, and is therefore useful as a prophylactic and/or therapeutic agent for a disease associated w ith aqueous humor circulation and/or ocular tension, particularly a prophyla ctic and/or therapeutic agent for glaucoma, ocular hypertension or the like. |
---|